ADCETRIS sales over time
Loncar_SalesSnapshot 19.6.jpg

This page will track the quarterly sales of Seattle Genetics' CD30 targeted antibody-drug conjugate ADCETRIS over time. This is net U.S. and Canada sales only and does not include international royalties from Takeda.